Atrium C-Qur Mesh Lawsuit Filed Over Hernia Repair Complications
Atrium Medical faces a lawsuit over its C-QUR mesh, which a Louisiana man says adhered to his bowel and twisted it, causing multiple ulcers, infection and other injuries.
Tag Archives: Mesh
-
-
XenMatrix Recall: Surgical Grafts May Not Meet FDA Safe Toxicity Levels
Davol, a subsidiary of C.R. Bard, has announced that it is issuing a recall for XenMatrix, a hernia and abdominal surgical graft, due to a failure to meet the FDA’s…
-
MDL Trials For Kugel Hernia Patch Lawsuits Set for May and July 2011
The next two trial dates in the federal Kugel hernia patch litigation are scheduled to begin in May and July 2011, marking the third and fourth “bellwether” lawsuits to reach…
-
Bard Avault Pelvic Support System Lawsuit MDL Hearing Set for Sept 30
A panel of federal judges will hear oral arguments next week about whether to consolidate a growing number of lawsuits over the Bard Avaulta Pelvic Support System, which have been…
-
Counterfeit Polypropylene Mesh Marketed as Bard Surgical Mesh: FDA
The FDA is warning that health care professionals may have been sold a counterfeit surgical mesh under the C.R. Bard brand name, which could put patients in danger.
-
Kugel Hernia Patch Trial Set to Begin March 25
The first of more than 1,000 Kugel hernia patch lawsuits has been scheduled for trial to begin on March 25 in the federal MDL.
-
Kugel Hernia Patch Lawyers To Meet With Court About Bellwether Trials
Lawyers from both sides in the Kugel Hernia Patch litigation will meet tomorrow in federal court to discuss the first “bellwether” trials that are scheduled out of more than 1,000…
-
First Kugel Hernia Mesh Lawsuit Scheduled for March 2010 Trial in MDL
Chief Judge Mary M. Lisi, who is presiding over the consolidated Kugel hernia mesh lawsuits that have been centralized in an MDL (Multidistrict Litigation) in the District of Rhode Island,…
-
Kugel Hernia Patch Manufacturer Cited for Violations at Puerto Rico Plant
The FDA released a warning letter yesterday that was sent to C.R. Bard, Inc. regarding “adulterated” medical products manufactured at their plant in Puerto Rico, which is where the company…
